Heimdall Insights

Global Nucleic Acid Amplification Testing Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Nucleic Acid Amplification Testing Market was valued at $10.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 9.5% CAGR, to an estimated market size of $16.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Nucleic Acid Amplification Testing (NAAT) market comprises molecular diagnostic technologies and assays designed to detect and amplify specific DNA or RNA sequences to identify pathogens or genetic markers. The scope includes PCR-based platforms, isothermal amplification (INAAT), and next-generation sequencing (NGS) used across infectious disease diagnostics, oncology, genetic testing, and blood screening, while excluding traditional culture-based methods and simple rapid antigen tests.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Nucleic Acid Amplification Testing Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Infectious Disease Testing
  • Oncology & Precision Medicine
  • Genetic Testing & Others